National Center of Infectious and Parasitic Diseases (NCIPD)

What National Center of Infectious and Parasitic Diseases (NCIPD) does

NCIPD is Bulgaria's national reference and research center for infectious and parasitic diseases, operating under the Bulgarian Ministry of Health. The center delivers specialized diagnostic laboratory services, epidemiological surveillance, antimicrobial resistance monitoring, and outbreak response support to the Bulgarian healthcare system, government health authorities, and (on a limited direct basis) patients and healthcare professionals. It is organized into five core departments — Immunology and Allergy, Epidemiology and Infectious Disease Surveillance, Microbiology, Parasitology and Tropical Medicine, and Virology — each containing multiple National Reference Laboratories (NRLs) and specialized expert laboratories covering pathogens ranging from HIV, hepatitis, influenza, and SARS-CoV-2 to tuberculosis, sexually transmitted infections, vector-borne diseases, and parasitic/tropical infections.

The center operates advanced laboratory infrastructure including Biosafety Level 3 (BSL-3) facilities for high-risk pathogen work, next-generation sequencing platforms (ABI 3500xl, Illumina MiSeq, NextSeq550) for whole genome analysis of priority public-health viruses, a Hitachi HT7800 transmission electron microscope for ultrastructural characterization of pathogens, MALDI-TOF mass spectrometry for bacterial and fungal identification, and a BD FACSAria Fusion 19-parameter flow cytometer for complex immunological analyses. NCIPD also maintains a Biological Bank of characterized pathogen strains, vaccine strains, and clinical samples for diagnostic, reference, and research purposes, and operates dedicated surveillance gateways for influenza/ARD, measles/mumps/rubella, and acute flaccid paralysis.

NCIPD is funded through a combination of government budget allocations from the Ministry of Health, EU research project funding (notably the Competence Centre 'Immunopathogen' under Operational Programme 'Science and Education for Smart Growth' 2014-2020 and the 'Research and Innovation for Smart Specialisation' Programme 2021-2027, project BG16RFPR002-1.014), and paid laboratory services with publicly disclosed euro-denominated test prices ranging from €8.44 (MALDI-TOF identification) to €303.20 (multiplex RNA transcript analysis). The institution holds accreditation for doctoral training across six scientific specialties, collaborates with WHO and ECDC, and conducts roughly 14-18 public procurement procedures annually for laboratory reagents, consumables, and equipment. Marketing and distribution occur through official channels, scientific publications, public procurement, and an E-Services portal rather than commercial sales motions.

Name

National Center of Infectious and Parasitic Diseases (NCIPD)

Legal name

Национален Център по Заразни и Паразитни Болести (National Center of Infectious and Parasitic Diseases)

Website

https://ncipd.org

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

NCIPD is Bulgaria's national reference center for infectious and parasitic diseases, operating under the Ministry of Health. It provides diagnostic laboratory services, epidemiological surveillance, BSL-3 high-risk pathogen analysis, whole genome sequencing, antimicrobial resistance monitoring, and doctoral training to hospitals, government authorities, and healthcare professionals.

Ownership category

akta.pro rank

Product category

Public Health Laboratory Services

NAICS

Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAJAIAA

National Public Health Reference Laboratories

Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks

SECONDARYHLAFAMAD

Microbiology & Infectious Disease Testing Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAAALAC

Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)

Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)

SECONDARYHLAJAIAM

Laboratory Quality Systems, Accreditation & Proficiency Testing Programs

Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks

SECONDARYHLAGAEAA

Central Laboratory Services (Core Lab Operations)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

• Infectious disease diagnostics
• Epidemiological surveillance
• Reference laboratory services
• Antimicrobial resistance monitoring
• Public health research

Headquarters

HQ city

Sofia

HQ country

Bulgaria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Laboratory Diagnostic Services: The center provides paid laboratory diagnostic services for various infectious diseases, immunological tests, and specialized analyses to healthcare facilities and individuals. Pricing is publicly available in euros for specific tests.
2. Government Funding: As a national public health institute under the Bulgarian Ministry of Health, NCIPD receives government funding for core public health functions including epidemiological surveillance, outbreak response, and national reference laboratory services.
3. EU Research Project Funding: Funding from EU programs including the Science and Education for Smart Growth Operational Programme and the Research and Innovation for Smart Specialisation Programme 2021-2027 for the Competence Centre 'Immunopathogen'.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

NCIPD provides specialized diagnostic laboratory testing for infectious and parasitic diseases across five departments (Microbiology, Virology, Parasitology and Tropical Medicine, Immunology and Allergy, and Epidemiology). It also delivers national epidemiological surveillance, outbreak investigation, antimicrobial resistance monitoring, doctoral and continuing education training, and applied research through the EU-funded Competence Centre 'Immunopathogen'. Services are accessed via healthcare provider referrals, direct patient consultations at specialized outpatient clinics, and government public health coordination.

Product overview

NCIPD offers a comprehensive suite of infectious and parasitic disease diagnostic services organized into five core laboratory departments (Microbiology, Virology, Parasitology and Tropical Medicine, Immunology and Allergy, and Epidemiology), each containing specialized reference laboratories (NRL) and diagnostic cabinets. The center operates a Competence Center called IMMUNOPATOGEN that conducts fundamental, translational, and clinical research in infections and infectious immunology. Key sub-products include BSL-3 high-risk pathogen laboratories, expert laboratories for whole genome sequencing (using ABI, Illumina platforms), electron microscopy (Hitachi HT7800), MALDI-TOF mass spectrometry, and flow cytometry (BD FACSAria Fusion). NCIPD also provides an E-services portal, epidemiological surveillance bulletins, external quality assessment for laboratories, and maintains a biological bank and training complex for doctoral and continuing education programs.

Differentiator

Problem solved

Functional benefit

Brands

• Център за компетентност 'Имунопатоген' (Competence Center 'Immunopathogen'): Competence Center conducting fundamental, translational and clinical research in infections and infectious immunology, funded by EU programmes. Project BG16RFPR002-1.014-0001-C01 under the Research, Innovation and Digitization Programme 2021-2027.

Products and services

• Laboratory Diagnostic Services - Microbiology Comprehensive microbiological diagnostics including antimicrobial resistance monitoring, molecular microbiology, enteric infections, dangerous bacterial infections, vector-borne infections, mycoses, tuberculosis, and sexually transmitted infections, provided to Bulgarian hospitals, clinics, and healthcare facilities as reference-level testing.
• Laboratory Diagnostic Services - Virology Virology diagnostics covering HIV, herpes and oncogenic viruses, measles/mumps/rubella, hepatitis viruses, influenza and acute respiratory diseases, enteroviruses, and rickettsiae with cell cultures, serving as Bulgaria's national reference laboratory for viral pathogens.
• Laboratory Diagnostic Services - Parasitology and Tropical Medicine Diagnostic services for parasitic diseases including zoonotic and transposable parasitoses, with a national consultative cabinet for parasitic and tropical diseases serving travelers and clinicians.
• Laboratory Diagnostic Services - Immunology and Allergy Immunology and allergy diagnostics including an expert laboratory for complex immunological analyses, an allergy cabinet, and the National Reference Laboratory for Immunology serving patients with complex immunological and allergic conditions.
• Epidemiological Surveillance and Outbreak Response National epidemiological surveillance, infection epidemiology, early warning and response, information technology systems, disinfection services, and medical arachnoentomology for vector-borne disease control, delivered to the Bulgarian Ministry of Health and regional health inspectorates.
• High-Risk Pathogen Laboratory (BSL-3) Specialized Biosafety Level 3 laboratory service providing rapid diagnostics using molecular, microscopic, and cultural methods for severe hemorrhagic fevers, bioterrorist agents, and emerging pathogens with pandemic potential, available only to authorized healthcare and government entities in Bulgaria.
• Whole Genome Sequencing of Viruses Whole genome and targeted sequencing analysis of viruses of public health importance including influenza, SARS-CoV-2, HIV, HBV, HCV, measles, rubella, and arboviruses using ABI 3500xl, Illumina MiSeq, and NextSeq550 sequencers, delivered to public health authorities and research collaborators.
• Competence Centre IMMUNOPATOGEN Research Services Research services under the EU-funded IMMUNOPATOGEN Competence Centre including molecular epidemiology, antimicrobial resistance mechanisms, diagnostic method development, protective immunity biomarkers, and microbiome research, available to academic and clinical research collaborators.
• External Quality Assessment (EQA) for Diagnostic Laboratories Quality assessment services for diagnostic laboratories in Microbiology, Virology, Parasitology, and Mycology, providing proficiency testing programs to clinical laboratories across Bulgaria.
• Doctoral and Continuing Education Training Programs Specialized training programs for infectious disease professionals including accredited doctoral programs in six scientific specialties, continuing education courses (СДО), and individual training placements, delivered to medical doctors, researchers, and laboratory specialists.

Quantifiable outcome

• Whole genome sequencing capability for SARS-CoV-2, influenza, HIV, HBV, HCV, measles, rubella, and arboviruses
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• World Health Organization (WHO)coreStrategic or Co-development PartnerInternational collaboration with WHO for infectious disease surveillance, outbreak investigation support, and standardization of diagnostic methods. The center participates in WHO networks and receives technical guidance on emerging pathogens and pandemic preparedness.
• European Centre for Disease Prevention and Control (ECDC)coreStrategic or Co-development PartnerCollaboration with ECDC for European infectious disease surveillance, antimicrobial resistance monitoring, and epidemic intelligence sharing. NCIPD contributes data to ECDC surveillance systems and participates in joint outbreak investigations.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Others

• European Centre for Disease Prevention and Control (ECDC): EU agency coordinating European infectious disease surveillance and response. NCIPD collaborates with ECDC as a national contact point and data contributor, making ECDC the relevant ecosystem partner rather than a direct competitor.
• World Health Organization (WHO) Regional Office for Europe: WHO's European regional body coordinating infectious disease surveillance and reference laboratory networks. NCIPD participates in WHO networks and standardization programs, making WHO a strategic ecosystem partner and standards-setter.

Broad incumbents

• Pasteur Institute: France's internationally renowned infectious disease research and reference institution. Comparable as a national reference center combining diagnostics, research, and surveillance, though with a much larger global footprint and research portfolio.

Direct peers

• Swiss Tropical and Public Health Institute: Switzerland's national institute for tropical and public health research. Comparable through its focus on infectious and parasitic diseases, reference laboratory services, and doctoral training programs in public health.
• Robert Koch Institute: Germany's federal government agency for disease control and prevention. Directly comparable as a national public health reference laboratory providing infectious disease diagnostics, surveillance, reference lab functions, and outbreak response, though operating at materially larger scale.
• Public Health Agency of Sweden (Folkhälsomyndigheten): Sweden's national public health agency responsible for infectious disease surveillance, diagnostics coordination, and outbreak response. Directly comparable in mandate as a state-funded national reference institution.
• National Institute for Public Health and the Environment (RIVM): Netherlands' national public health reference institute. Comparable as a government reference center providing infectious disease diagnostics, surveillance, and antimicrobial resistance monitoring with WHO and ECDC integration.
• Statens Serum Institut: Denmark's national public health and research institute. Comparable as a state-owned infectious disease reference center providing diagnostics, surveillance, antimicrobial resistance monitoring, and research services with a similar integrated mandate.

Regional players

• Bernhard Nocht Institute for Tropical Medicine: Germany's reference center for tropical and emerging infectious diseases. Comparable in BSL-4/BSL-3 capability, parasitic disease diagnostics, and national reference laboratory functions, though focused on tropical medicine.
• National Reference Laboratories Network of Greece (EODY): Greece's national public health organization operating reference laboratories for infectious diseases. Comparable as a regional peer serving a similar Balkan/Mediterranean population with analogous mandate in surveillance and reference diagnostics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/national-center-of-infectious-and-parasitic-diseases

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Center of Infectious and Parasitic Diseases (NCIPD)